pik3ca-testing.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Sitemap: https://www.pik3ca-testing.com/sitemap.xml Disallow: | ||
Meta Tags
| Title | PIK3CA Mutation Testing in Metastatic Breast |
| Description | Learn about FDA-approved PIK3CA mutation CDx tests and why knowledge of PIK3CA mutation status can inform upfront HR+/HER2- mBC management for appropriate |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 217.114.85.100 |
| Location | Sweden |
Related Websites
| Site | Rank |
More to Explore
pik3ca-testing.com Valuation
|
US$1,137,595
Last updated: 2023-05-18 02:36:21
pik3ca-testing.com has Semrush global rank of 9,304,108. pik3ca-testing.com has an estimated worth of US$ 1,137,595, based on its estimated Ads revenue. pik3ca-testing.com receives approximately 131,261 unique visitors each day. Its web server is located in Sweden, with IP address 217.114.85.100. According to SiteAdvisor, pik3ca-testing.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,137,595 |
| Daily Ads Revenue | US$1,051 |
| Monthly Ads Revenue | US$31,503 |
| Yearly Ads Revenue | US$378,032 |
| Daily Unique Visitors | 8,751 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| pik3ca-testing.com. | A | 21600 | IP: 217.114.85.100 |
| pik3ca-testing.com. | NS | 1800 | NS Record: dns3.novartis.com. |
| pik3ca-testing.com. | NS | 1800 | NS Record: a24-65.akam.net. |
| pik3ca-testing.com. | NS | 1800 | NS Record: a28-67.akam.net. |
| pik3ca-testing.com. | NS | 1800 | NS Record: a2-66.akam.net. |
| pik3ca-testing.com. | NS | 1800 | NS Record: dns2.novartis.com. |
| pik3ca-testing.com. | NS | 1800 | NS Record: a9-65.akam.net. |
| pik3ca-testing.com. | NS | 1800 | NS Record: dns1.novartis.com. |
| pik3ca-testing.com. | NS | 1800 | NS Record: a1-254.akam.net. |
| pik3ca-testing.com. | NS | 1800 | NS Record: a7-64.akam.net. |
| pik3ca-testing.com. | NS | 1800 | NS Record: dns4.novartis.com. |
HtmlToTextCheckTime:2023-05-18 02:36:21
| This is for US residents only. Information about PIQRAY ® (alpelisib) tablets PIK3CA Testing Navigator Toggle navigation Testing information Multi-gene testing (NGS) Single-gene testing (PCR) Background Resources/FAQs × Foundation Medicine’s FoundationOne®CDx and FoundationOne®Liquid CDx are FDA approved as companion diagnostics for PIQRAY® (alpelisib) tablets Explore all the ways to navigate PIK3CA mutation testing for HR+/HER2- advanced breast cancer. Follow Pik Nav, your informative guide, as she walks you through a short video on available FDA-approved PIK3CA mutation CDx tests. Watch her video × Indication PIQRAY® (alpelisib) tablets is indicated in combination with fulvestrant for the treatment of postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advanced or metastatic breast cancer as detected by an FDA-approved test following progression on or after an endocrine-based regimen. Important |
HTTP Headers
HTTP/1.0 301 Moved Permanently Location: https://www.pik3ca-testing.com/ Server: BigIP Connection: Keep-Alive Content-Length: 0 HTTP/2 200 date: Sat, 07 May 2022 09:25:19 GMT content-type: text/html; charset=utf-8 access-control-expose-headers: Request-Context cache-control: private set-cookie: ASP.NET_SessionId=lmnypfyvseuvgdlvf1fxcvnm; path=/; secure; HttpOnly; SameSite=Lax vary: Accept-Encoding request-context: appId=cid-v1:fbded6d8-2f5c-4cb0-adf7-2ae9d814644f x-xss-protection: 1; mode=block x-content-type-options: nosniff strict-transport-security: max-age=31536000; includeSubDomains x-frame-options: SAMEORIGIN set-cookie: ASP.NET_SessionId=lmnypfyvseuvgdlvf1fxcvnm; path=/; secure; HttpOnly; SameSite=Lax set-cookie: __RequestVerificationToken=dN2ORy2FWu29lDP5FignJmh4dJ3gDxfVcl4j9hDgRSqXkQjRJ9Od7r9P4axNQcJF59AThFkzg_0pAZHjQg5t7pqQP4QiLxzXFPLOce7XR5Y1; path=/; secure; HttpOnly set-cookie: ARRAffinity=b81aa34fe2d3e0317875bddac6d538deed2ec2016e12d5040607666d20c8b86f;Path=/;HttpOnly;Secure;Domain=www.pik3ca-testing.com set-cookie: ARRAffinitySameSite=b81aa34fe2d3e0317875bddac6d538deed2ec2016e12d5040607666d20c8b86f;Path=/;HttpOnly;SameSite=None;Secure;Domain=www.pik3ca-testing.com cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" server: cloudflare cf-ray: 7078e85d4b62376e-HEL |
pik3ca-testing.com Whois Information
Domain Name: PIK3CA-TESTING.COM Registry Domain ID: 2443812484_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2021-09-14T02:03:36Z Creation Date: 2019-10-15T15:46:23Z Registry Expiry Date: 2023-10-15T15:46:23Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2086851750 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: A1-254.AKAM.NET Name Server: A2-66.AKAM.NET Name Server: A24-65.AKAM.NET Name Server: A28-67.AKAM.NET Name Server: A7-64.AKAM.NET Name Server: A9-65.AKAM.NET Name Server: DNS1.NOVARTIS.COM Name Server: DNS2.NOVARTIS.COM Name Server: DNS3.NOVARTIS.COM Name Server: DNS4.NOVARTIS.COM DNSSEC: unsigned >>> Last update of whois database: 2022-05-07T10:26:02Z <<< |